http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-3870-U1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b170da10b2e38eaf18a8b3852790241a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate | 2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55dc4e7fca101586d5fa1b4e6abb4678 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1f3b3e3b0fc6afb76d9d5960d8c1d1c |
| publicationDate | 2020-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BG-3870-U1 |
| titleOfInvention | ORAL SOLUTION GRANULES CONTAINING KETOPROFEN |
| abstract | The utility model relates to a composition of granules containing ketoprofen, in particular ketoprofen lysine salt, mannitol, povidone K25, anhydrous silica, sodium chloride, sweetener and flavor, in the following weight ratios of the components in the composition: 80 mg ketoprofen lysine salt, 1701 to 1735 mg mannitol, 66 to 100 mg povidone K25, 4 mg anhydrous silica, 150 mg sweetener, 40 to 45 mg flavoring and 20 mg sodium chloride. The sweetener used in the composition of the granules is a combination of saccharin sodium and saccharin cyclamate mixed in a ratio of 1: 6 to 1:10. The advantages of the granules for oral solution, according to the utility model, are their good rheological properties, uniform distribution of the active substance, good and fast solubility, which results in a clear and stable solution with good organoleptic characteristics. |
| priorityDate | 2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.